Leases (Tables)

9 Months Ended

Sep. 30, 2025

Leases [Abstract]

Schedule of Lease, Cost

The components of the Company’s lease expense are as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Operating lease expense	$	4,316	$	3,695	$	12,326	$	11,165
Short-term lease expense	159		198		443		590

Supplemental cash flow information related to the Company’s leases is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024		2025		2024
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	4,288	$	3,632	$	12,133	$	11,029
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities	1,475		691		11,957		6,055

Supplemental balance sheet information related to the Company’s leases is as follows:

	September 30, 2025			December 31, 2024
Right-of-use lease assets	$	38,454		$	34,120
Other accrued liabilities	12,441			10,619
Long-term lease liabilities	22,637			20,028
Total operating lease liabilities	$	35,078		$	30,647
Weighted average remaining lease term (years)	4.9			5.0
Weighted average discount rate	6.23		%	5.63		%

Schedule of Lessee, Operating Lease, Liability, Maturity

Maturities of operating lease liabilities as of September 30, 2025 were as follows:

For the remainder of 2025	$	4,076
For the year ended December 31, 2026	12,844
For the year ended December 31, 2027	8,254
For the year ended December 31, 2028	5,530
For the year ended December 31, 2029	3,412
For the year ended December 31, 2030 and beyond	6,603
Total lease payments	40,719
Less: imputed interest	(5,641)
Present value of lease liabilities (1)	$	35,078

(1) During the year ended December 31, 2024, the Company entered into a new lease agreement for office and laboratory space in Radnor, Pennsylvania for the purpose of relocating its global headquarters. The lease for one portion of the laboratory space is expected to commence in the second quarter of 2026. The lease for the remaining portions of laboratory and office space is expected to commence upon the completion of the lessor owned leasehold improvements, which is expected to be in the second half of 2026. The cumulative future lease commitment for the laboratory and office space is $79.7 million. The future lease commitments relating to this lease were not included in the lease liabilities balance as of September 30, 2025.